Colon inflammatory polyp

Summary

Colon inflammatory polyp (MONDO:0006152) is a disease. A subtype of colonic neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	colon inflammatory polyp
Mondo ID	MONDO:0006152
EFO	EFO:1000184
NCIT	C5517
UMLS	C0267392
MedGen	78627
Is cancer (heuristic)	no

Also known as: colonic inflammatory polyp · inflammatory polyp of colon · inflammatory polyp of the colon

Disease family

This is a subtype of colonic neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › large intestine disorder › colonic disorder › colonic neoplasm › colon inflammatory polyp

Related subtypes (7): benign colon neoplasm, colon neuroendocrine neoplasm, cecal neoplasm, colon juvenile polyp, sigmoid neoplasm, malignant colon neoplasm, epithelial tumor of colon

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.